Is dual tracer PET/CT a prognostic biomarker in the PRRT enrollment of GEP-NET patients?

Autor: Pignata, Sa, Campennı`, A, Minutoli, F, Laudicella, R, Comis, A, Filice, R, Catalfamo, B, Panasiti, F, Baldari, S

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3978::601fa834961e15445f50750f9caceb8a
http://hdl.handle.net/11570/3168903

Complete response in a pancreatic NEN with liver metastasis after PRRT in association with lanreotide autogel/depot

Autor: Laudicella, R, Minutoli, F, Filice, R, Baratto, L, Vento, A, Pignata, Sa, Cardile, D, Pagano, B, Baldari, S

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3978::76487a03bbea2ca2f0ace21088989f6f
http://hdl.handle.net/11570/3168907

Activity of chemotherapy in mucinous ovarian cancer with a recurrence free interval of more than 6 months: results from the SOCRATES retrospective study

Autor: Alletti Desiderio, Breda Enrico, Lauria Rossella, Manzione Luigi, Ghezzi Fabio, Mereu Liliana, Villa Antonella, Katsaros Dionyssios, Cormio Gennaro, Odicino Franco, Scollo Paolo, Scarfone Giovanna, Ferrandina Gabriella, Pignata Sandro, Ballardini Michela, Lombardi Alessandra, Sorio Roberto, Mangili Giorgia, Priolo Domenico, Magni Giovanna, Morabito Alessandro

Publikováno v: BMC Cancer, Vol 8, Iss 1, p 252 (2008)

Abstract Background Mucinous ovarian carcinoma have a poorer prognosis compared with other histological subtypes. The aim of this study was to evaluate, retrospectively, the activity of chemotherapy in patients with platinum sensitive recurrent mucin

Externí odkaz: https://doaj.org/article/64266de6d8874f28baf9f3562c637702

Tamoxifen is not effective in good prognosis patients with hepatocellular carcinoma

Autor: Daniele Bruno, Signoriello Giuseppe, Di Maio Massimo, De Maio Ermelinda, Gallo Ciro, Pignata Sandro, Annunziata Annalisa, Perrone Francesco

Publikováno v: BMC Cancer, Vol 6, Iss 1, p 196 (2006)

Abstract Background Large randomised clinical trials and systematic reviews substantiate that tamoxifen is ineffective in improving survival of patients with hepatocellular carcinoma (HCC). However, a recent report suggested that the drug might prolo

Externí odkaz: https://doaj.org/article/0fb37acdbf954f4b81889a4f539d6203

Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors.

Autor: Pusceddu S; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, European Neuroendocrine Tumor Society (ENETS) Center of Excellence, Milan, Italy., Prinzi N; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, European Neuroendocrine Tumor Society (ENETS) Center of Excellence, Milan, Italy., Tafuto S; Oncologia Clinica e Sperimentale Sarcomi e Tumori Rari, Istituto Nazionale Tumori IRCCS, Fondazione G. Pascale, Naples, Italy., Ibrahim T; Osteoncology and Rare Tumors Center, IRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori,' Meldola, Italy., Filice A; Nuclear Medicine Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, Italy., Brizzi MP; Azienda Ospedaliera Universitaria San Luigi Gonzaga, Orbassano, Italy., Panzuto F; Digestive Disease Unit, Sant'Andrea University Hospital, ENETS Center of Excellence, Rome, Italy., Baldari S; Department of Biomedical and Dental Sciences and Morphofunctional Imaging, Nuclear Medicine Unit, University of Messina, Messina, Italy., Grana CM; Division of Nuclear Medicine, IRCCS Istituto Europeo di Oncologia, Milan, Italy., Campana D; Department of Experimental Diagnostic and Specialized Medicine, Alma Mater Studiorum, University of Bologna, Bologna, Italy.; Division of Medical Oncology, IRCCS Azienda Ospedaliera-Universitaria Bologna, Neuroendocrine Tumor Team Bologna, ENETS Center of Excellence Bologna, Bologna, Italy., Davì MV; Department of Medicine, Section of Endocrinology, University and Hospital Trust of Verona, ENETS Center of Excellence, Verona, Italy., Giuffrida D; Oncologia Medica, Istituto Oncologico del Mediterraneo, Viagrande (Catania), Italy., Zatelli MC; Department of Medical Sciences, Section of Endocrinology, Geriatrics and Internal Medicine, University of Ferrara, Ferrara, Italy., Partelli S; Pancreatic Surgery, Pancreas Translational and Clinical Research Center, San Raffaele Hospital IRCCS, Università Vita-Salute San Raffaele, ENETS Center of Excellence, Milano, Italy., Razzore P; Department of Internal Medicine, Division of Endocrinology, A.O. Ordine Mauriziano, Turin, Italy., Marconcini R; Department of Oncology, Santa Chiara Hospital, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy., Massironi S; Division of Gastroenterology, Ospedale San Gerardo, University of Milano-Bicocca, Monza, Italy., Gelsomino F; Department of Oncology and Haematology, University Hospital of Modena, Modena, Italy., Faggiano A; Department of Clinical and Molecular Medicine, Endocrinology Unit, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy., Giannetta E; Department of Experimental Medicine, Sapienza Università Roma, Rome, Italy., Bajetta E; Istituto di Oncologia, Policlinico di Monza, Monza, Italy., Grimaldi F; Endocrinology and Metabolism Unit, University Hospital S. Maria della Misericordia, Udine, Italy., Cives M; Department of Biomedical Sciences and Human Oncology, University of Bari, Bari, Italy.; National Cancer Center, Tumori Institute Giovanni Paolo II, Bari, Italy., Cirillo F; Department of Surgery, General Surgery Unit, Gruppo Tumori Rari, Azienda Socio-Sanitaria Territoriale-Cremona, Cremona, Italy., Perfetti V; ASST-Pavia Medicina Interna Varzi, Varzi, Italy., Corti F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, European Neuroendocrine Tumor Society (ENETS) Center of Excellence, Milan, Italy., Ricci C; Division of Pancreatic Surgery, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy.; Department of Internal Medicine and Surgery, Alma Mater Studiorum, University of Bologna, Bologna, Italy., Giacomelli L; Polistudium, Milan, Italy., Porcu L; Methodology for Clinical Research Laboratory, Oncology Department, IRCCS Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy., Di Maio M; Department of Oncology, University of Turin, A.O. Ordine Mauriziano, Torino, Italy., Seregni E; Department of Nuclear Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, ENETS Center of Excellence, Milan, Italy., Maccauro M; Department of Nuclear Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, ENETS Center of Excellence, Milan, Italy., Lastoria S; Nuclear Medicine Unit, Istituto Nazionale Tumori IRCCS, Fondazione G. Pascale, Naples, Italy., Bongiovanni A; Osteoncology and Rare Tumors Center, IRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori,' Meldola, Italy., Versari A; Nuclear Medicine Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, Italy., Persano I; Azienda Ospedaliera Universitaria San Luigi Gonzaga, Orbassano, Italy., Rinzivillo M; Digestive Disease Unit, Sant'Andrea University Hospital, ENETS Center of Excellence, Rome, Italy., Pignata SA; Department of Biomedical and Dental Sciences and Morphofunctional Imaging, Nuclear Medicine Unit, University of Messina, Messina, Italy.; Nuclear Medicine Unit, Azienda Ospedaliera Papardo, Messina, Italy., Rocca PA; Division of Nuclear Medicine, IRCCS Istituto Europeo di Oncologia, Milan, Italy., Lamberti G; Department of Experimental Diagnostic and Specialized Medicine, Alma Mater Studiorum, University of Bologna, Bologna, Italy.; Division of Medical Oncology, IRCCS Azienda Ospedaliera-Universitaria Bologna, Neuroendocrine Tumor Team Bologna, ENETS Center of Excellence Bologna, Bologna, Italy., Cingarlini S; Department of Medicine, Oncology, University and Hospital Trust of Verona, ENETS Center of Excellence, Verona, Italy., Puliafito I; Oncologia Medica, Istituto Oncologico del Mediterraneo, Viagrande (Catania), Italy., Ambrosio MR; Department of Medical Sciences, Section of Endocrinology, Geriatrics and Internal Medicine, University of Ferrara, Ferrara, Italy., Zanata I; Department of Medical Sciences, Section of Endocrinology, Geriatrics and Internal Medicine, University of Ferrara, Ferrara, Italy., Bracigliano A; Oncologia Clinica e Sperimentale Sarcomi e Tumori Rari, Istituto Nazionale Tumori IRCCS, Fondazione G. Pascale, Naples, Italy., Severi S; Nuclear Medicine Therapy Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori,' Meldola, Italy., Spada F; Division of Medical Oncology, IRCCS Istituto Europeo di Oncologia, Milan, Italy., Andreasi V; Pancreatic Surgery, Pancreas Translational and Clinical Research Center, San Raffaele Hospital IRCCS, Università Vita-Salute San Raffaele, ENETS Center of Excellence, Milano, Italy., Modica R; Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy., Scalorbi F; Department of Nuclear Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, ENETS Center of Excellence, Milan, Italy., Milione M; First Division of Pathology, Department of Pathology and Laboratory Medicine, IRCCS Foundation National Cancer Institute, Milan, Italy., Sabella G; First Division of Pathology, Department of Pathology and Laboratory Medicine, IRCCS Foundation National Cancer Institute, Milan, Italy., Coppa J; Gastro-entero-pancreatic Surgical and Liver Transplantation Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, ENETS Center of Excellence, Milan, Italy., Casadei R; Division of Pancreatic Surgery, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy.; Department of Internal Medicine and Surgery, Alma Mater Studiorum, University of Bologna, Bologna, Italy., Di Bartolomeo M; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, European Neuroendocrine Tumor Society (ENETS) Center of Excellence, Milan, Italy., Falconi M; Pancreatic Surgery, Pancreas Translational and Clinical Research Center, San Raffaele Hospital IRCCS, Università Vita-Salute San Raffaele, ENETS Center of Excellence, Milano, Italy., de Braud F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, European Neuroendocrine Tumor Society (ENETS) Center of Excellence, Milan, Italy.; Department of Oncology and Hemato-Oncology, Università deli Studi di Milano, Milan, Italy.

Publikováno v: JAMA network open [JAMA Netw Open] 2022 Feb 01; Vol. 5 (2), pp. e220290. Date of Electronic Publication: 2022 Feb 01.